REPORTING
EPICURVE
OUTBREAK INVESTIGATION
HEALTH SURVEILLANCE
100

What is the basic epidemiological report format in NATO

EPINATO 2

100

Describe epidemic curve of one point source infection?

Gausse curve

100

What is an outbreak?

Higher number of cases than expected.

100

What is the definition of health surveillance?

Ongoing and systematic collection, analysis, and interpretation of health related data essential to planning.

200

What is the frequency of EPINATO 2?

Weekly

200

How does the EPI Curve of a continuous source infection look like?

Draw EPI curve

200

What are the objectives of an outbreak investigation?

Stop present outbreak and prevent next one.

200

Clinical case definition must include a balance between ________and _________?

Specificity and Sensitivity

300

Do we count only the first medical consultation in EPINATO2?

NO

300

What information is required to draw the EPICURVE?

Case Definition 

Number of Cases

Time

300

What are the two stages of an outbreak investigation?

Descriptive and Analytic

300

What is the surveillance cycle?

Collect

Analyze

Interpret

Disseminate

ACT

400

What type of surveillance is EPINATO 2?

Passive surveillance

400

What is the required information for a case definition? 

Place 

Time

Symptoms / Diagnosis

400

What are the steps of the Descriptive stage?

Confirm outbreak

Confirm diagnosis

Case definition

Active case finding

Describe data

400

What are the 2 types of surveillance groups?

Disease and Syndromic

500

What are the advantages and disadvantages of EPINATO 2?

Advantages: shows trends, summary report to MedAD

Disadvantage: time lag, quality of data

500

Why is it important to draw the EPI CURVE during an outbreak?

It shows trends in the outbreak and helps to identify the cause. 

500

What are the steps of the analytic stage?

Develop hypothesis

Confirm hypothesis

Synthesis of results with hypothesis and results

Countermeasures

Report and communincation

500

Where can the definition of health surveillance be found?

AMed P 4.1/ STANAG 2535  

Deployment Health Surveillance 

M
e
n
u